✦ LIBER ✦

Four-month treatment with GLP-2 significantly increases hip BMD: A randomized, placebo-controlled, dose-ranging study in postmenopausal women with low BMD

✍ Scribed by Dennis B. Henriksen; Peter Alexandersen; Bolette Hartmann; Charlotte L. Adrian; Inger Byrjalsen; Henry G. Bone; Jens J. Holst; Claus Christiansen

Book ID: 116322479
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 897 KB
Volume: 45
Category: Article
ISSN: 8756-3282
DOI: 10.1016/j.bone.2009.07.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled study of a cathepsin-K inhibitor in the treatment of postmenopausal women with Low BMD: 18 month results

✍ Avery Ince; Michael McClung; Henry Bone; Nadia Verbruggen; Andrea Rybak-Feiglin; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 101 KB

The vitamin D analogue 2MD increases bon

The vitamin D analogue 2MD increases bone turnover but not BMD in postmenopausal women with osteopenia: Results of a 1-year phase 2 double-blind, placebo-controlled, randomized clinical trial

✍ Hector F DeLuca; Wendy Bedale; Neil Binkley; J Chris Gallagher; Michael Bolognes 📂 Article 📅 2011 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 215 KB 👁 1 views

## Abstract Most osteoporosis drugs act by inhibiting bone resorption. A need exists for osteoporosis therapies that stimulate new bone formation. 2‐Methylene‐19‐nor‐(20__S__)‐1α,25‐dihydroxyvitamin D~3~ (2MD) is a vitamin D analogue that potently stimulates bone formation activity in vitro and in